Testing behavioral interventions to increase intention to and use of modern contraception among women with at least one child

ISRCTN ISRCTN55316336
DOI https://doi.org/10.1186/ISRCTN55316336
Sponsors Surgo Ventures (now Surgo Health), Clinton Foundation
Funder Surgo Foundation
Submission date
05/03/2026
Registration date
09/03/2026
Last edited
09/03/2026
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Sema Sgaier
Public, Scientific, Principal investigator

1701 Rhode Island Avenue NW
Washington DC
20036
United States of America

Phone +1 206 330 6272
Email semasgaier@surgohealth.com

Study information

Primary study designInterventional
AllocationRandomized controlled trial
MaskingOpen (masking not used)
ControlActive
AssignmentSingle
PurposeHealth services research
Scientific titleUnderstanding the potential of interventions based on causal drivers in increasing intent and uptake of modern contraceptives (esp. MET) among single-parity women
Study objectives
Ethics approval(s)

Approved 27/05/2022, Convergent Institutional Review Board (Suit No-104, C-51, BSI Business Park, C-Block Ph-II, Sector-62, Noida, 201309, India; +91 (0)9999369375; info@convergentview.com), ref: 06/Convergent-IRB/2022-23

Health condition(s) or problem(s) studiedContraception among postpartum women
InterventionASHAs' (Community Health Workers') catchment areas in three blocks (Nasrullaganj, Shyampur, and Icchawar) of Sehore district, Madhya Pradesh, India, were randomly assigned to intervention or control arms. The random assignment was performed by using a random number generator using Excel. Enrolled participants in the ASHAs' catchment areas were then surveyed at baseline and follow-up.

Intervention arm:
Accredited social health activists (ASHAs) (community health workers) received training to deliver structured family planning counselling over five visits during a 5-month period (November 2022–March 2023).
The intervention included:
1. Counselling on birth spacing
2. Information on modern, effective, and temporary (MET) methods (daily oral pill, weekly oral pill, intrauterine device, injectable)
3. Printed behavior change communication (BCC) materials delivered in stages
4. Information on government service points for free access

Control arm:
ASHAs continued routine government family planning programming without structured intervention
Intervention typeBehavioural
Primary outcome measure(s)
  1. Current use of modern, effective, and temporary (MET) contraception measured using structured survey at 6 months after baseline survey (April–May 2023)
Key secondary outcome measure(s)
Completion date10/05/2023

Eligibility

Participant type(s)
Age groupMixed
Lower age limit18 Years
Upper age limit99 Years
SexFemale
Target sample size at registration1760
Total final enrolment1767
Key inclusion criteria1. Married women
2. At least one 1+ parity
3. Fecund and not currently pregnant
4. Neither woman nor spouse sterilized
5. 3 to 9 months postpartum at baseline enrollment
6. Had not opted for an irreversible contraception method
7. Planned to remain in the same locality for the upcoming 6 months
8. 18 years of age or over (to provide consent)
9. Provided informed consent
Key exclusion criteria1. Sterilized
2. Currently pregnant
3. Planning relocation within 6 months
4. Declined consent
Date of first enrolment06/09/2022
Date of final enrolment14/10/2022

Locations

Countries of recruitment

  • India

Study participating centres

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
IPD sharing planThe data generated during the current study are available upon request on a case-by-case basis. Please contact Dr Sema K. Sgaier at semasgaier@surgohealth.com.

Editorial Notes

06/03/2026: Study's existence confirmed by the Convergent Institutional Review Board.